Unknown

Dataset Information

0

MiR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma.


ABSTRACT: We aimed to determine the functional role of the miRNA, which affects drug sensitivity to 5-FU in oral squamous cell carcinoma (OSCC), using two types of 5-FU-resistant and parental OSCC cell lines. MiRNA microarray data showed that miR-30a was significantly upregulated in two resistant cell lines. Therefore, we investigated the effects and molecular mechanism of miR-30a on 5-FU sensitivity. Stable overexpression of miR-30a in parental OSCC cells decreased cell proliferation and attenuated drug sensitivity to 5-FU. Cell cycle analysis indicated that miR-30a overexpression increased the proportion of G1 phase cells and decreased the proportion of S phase cells. MiR-30a knockdown using siRNA reversed the effects of miR-30a overexpression. DNA microarray analysis using miR-30a-overexpressing cell lines and a TargetScan database search showed that cyclin E2 (CCNE2) is a target of miR-30a. A luciferase reporter assay confirmed that a miR-30a mimic interacted with the specific binding site in the 3' UTR of CCNE2. CCNE2 knockdown with siRNA in OSCC cells yielded decreased drug sensitivity to 5-FU, similar to miR-30a overexpressing cells. These findings suggest that miR-30a in OSCC may be a novel biomarker of 5-FU-resistant tumors, as well as a therapeutic target for combating resistance.

SUBMITTER: Kawahara K 

PROVIDER: S-EPMC8461355 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7244014 | biostudies-literature
| S-EPMC7761248 | biostudies-literature
| S-EPMC7131934 | biostudies-literature
| S-EPMC7262515 | biostudies-literature
| S-EPMC6959053 | biostudies-literature
| S-EPMC7463708 | biostudies-literature
| S-EPMC5725291 | biostudies-literature
| S-EPMC3944271 | biostudies-literature
| S-EPMC7774499 | biostudies-literature
| S-EPMC3241556 | biostudies-literature